Bloqueadores da puberdade (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bloqueadores da puberdade" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

18doi.org

2^nd place

4^th place

17nih.gov

4^th place

8^th place

3worldcat.org

5^th place

2books.google.com

3^rd place

6^th place

2mayoclinic.org

1,610^th place

991^st place

1hrc.org

5,694^th place

low place

1nhs.uk

1,989^th place

1,732^nd place

1nytimes.com

7^th place

14^th place

1web.archive.org

1^st place

books.google.com

Andropathy. [S.l.]: Urotext. 2 de março de 2003. pp. 120–. ISBN 978-1-903737-08-8
Becker, Kenneth L. (2001). Principles and Practice of Endocrinology and Metabolism. [S.l.]: Lippincott Williams & Wilkins. pp. 973–. ISBN 978-0-7817-1750-2

doi.org

dx.doi.org

Stevens J, Gomez-Lobo V, Pine-Twaddell E (dezembro de 2015). «Insurance Coverage of Puberty Blocker Therapies for Transgender Youth». Pediatrics. 136 (6): 1029–31. PMID 26527547. doi:10.1542/peds.2015-2849
Alegría CA (outubro de 2016). «Gender nonconforming and transgender children/youth: Family, community, and implications for practice». Journal of the American Association of Nurse Practitioners. 28 (10): 521–527. PMID 27031444. doi:10.1002/2327-6924.12363
Watson SE, Greene A, Lewis K, Eugster EA (junho de 2015). «Bird's-eye view of GnRH analog use in a pediatric endocrinology referral center». Endocrine Practice. 21 (6): 586–9. PMC 5344188. PMID 25667370. doi:10.4158/EP14412.OR
Panday K, Gona A, Humphrey MB (outubro de 2014). «Medication-induced osteoporosis: screening and treatment strategies». Therapeutic Advances in Musculoskeletal Disease. 6 (5): 185–202. PMC 4206646. PMID 25342997. doi:10.1177/1759720X14546350
Boyar RM (novembro de 2003). «Control of the onset of puberty». Annual Review of Medicine. 29: 509–20. PMID 206190. doi:10.1146/annurev.me.29.020178.002453
Rew, Lynn; Young, Cara C.; Monge, Maria; Bogucka, Roxanne (fevereiro de 2021). «Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature». Child and Adolescent Mental Health. 26 (1): 3–14. ISSN 1475-357X. doi:10.1111/camh.12437
Mahfouda S, Moore JK, Siafarikas A, Zepf FD, Lin A (outubro de 2017). «Puberty suppression in transgender children and adolescents». The Lancet Diabetes & Endocrinology. 5 (10): 816–826. PMID 28546095. doi:10.1016/s2213-8587(17)30099-2
Rafferty J (outubro de 2018). «Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents». Pediatrics. 142 (4): e20182162. PMID 30224363. doi:10.1542/peds.2018-2162
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. (novembro de 2017). «Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline». The Journal of Clinical Endocrinology and Metabolism. 102 (11): 3869–3903. PMID 28945902. doi:10.1210/jc.2017-01658
Rew, Lynn; Young, Cara; Monge, Maria; Bogucka, Roxanne (2021). «Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature». Child and Adolescent Mental Health. 26 (1): 3–14. doi:10.1111/camh.12437. Consultado em 5 de junho de 2022. Cópia arquivada em 20 de maio de 2022
Bangalore Krishna, Kanthi; Fuqua, John S.; Rogol, Alan D.; Klein, Karen O.; Popovic, Jadranka; Houk, Christopher P.; Charmandari, Evangelia; Lee, Peter A.; Freire, A. V. (2019). «Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium». Hormone Research in Paediatrics. 91 (6): 357–372. ISSN 1663-2826. PMID 31319416. doi:10.1159/000501336
Giovanardi G (setembro de 2017). «Buying time or arresting development? The dilemma of administering hormone blockers in trans children and adolescents». Porto Biomedical Journal. 2 (5): 153–156. PMC 6806792. PMID 32258611. doi:10.1016/j.pbj.2017.06.001
Tuvemo T (maio de 2006). «Treatment of central precocious puberty». Expert Opin Investig Drugs. 15 (5): 495–505. PMID 16634688. doi:10.1517/13543784.15.5.495
Eugster EA (maio de 2019). «Treatment of Central Precocious Puberty». J Endocr Soc. 3 (5): 965–972. PMC 6486823. PMID 31041427. doi:10.1210/js.2019-00036
Roth C (setembro de 2002). «Therapeutic potential of GnRH antagonists in the treatment of precocious puberty». Expert Opin Investig Drugs. 11 (9): 1253–9. PMID 12225246. doi:10.1517/13543784.11.9.1253
Rosenthal SM (outubro de 2021). «Challenges in the care of transgender and gender-diverse youth: an endocrinologist's view». Nat Rev Endocrinol. 17 (10): 581–591. doi:10.1038/s41574-021-00535-9
Neyman A, Fuqua JS, Eugster EA (abril de 2019). «Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents». J Adolesc Health. 64 (4): 544–546. PMC 6431559. PMID 30612811. doi:10.1016/j.jadohealth.2018.10.296
Schoelwer M, Eugster EA (2016). «Treatment of Peripheral Precocious Puberty». Endocr Dev. Endocrine Development. 29: 230–9. ISBN 978-3-318-02788-4. PMC 5345994. PMID 26680582. doi:10.1159/000438895

hrc.org

assets2.hrc.org

Supporting and Caring for Transgender Children (PDF) (Relatório). American Academy of Pediatrics. Setembro de 2016. p. 11

mayoclinic.org

«Pubertal blockers for transgender and gender diverse youth» (em inglês). Mayo Clinic. 16 de agosto de 2019. Consultado em 15 de dezembro de 2020
«Current treatments for endometriosis». Mayo Clinic

nhs.uk

«Gender dysphoria - Treatment». nhs.uk (em inglês). 3 de outubro de 2018. Consultado em 31 de março de 2022

nih.gov

ncbi.nlm.nih.gov

Stevens J, Gomez-Lobo V, Pine-Twaddell E (dezembro de 2015). «Insurance Coverage of Puberty Blocker Therapies for Transgender Youth». Pediatrics. 136 (6): 1029–31. PMID 26527547. doi:10.1542/peds.2015-2849
Alegría CA (outubro de 2016). «Gender nonconforming and transgender children/youth: Family, community, and implications for practice». Journal of the American Association of Nurse Practitioners. 28 (10): 521–527. PMID 27031444. doi:10.1002/2327-6924.12363
Watson SE, Greene A, Lewis K, Eugster EA (junho de 2015). «Bird's-eye view of GnRH analog use in a pediatric endocrinology referral center». Endocrine Practice. 21 (6): 586–9. PMC 5344188. PMID 25667370. doi:10.4158/EP14412.OR
Panday K, Gona A, Humphrey MB (outubro de 2014). «Medication-induced osteoporosis: screening and treatment strategies». Therapeutic Advances in Musculoskeletal Disease. 6 (5): 185–202. PMC 4206646. PMID 25342997. doi:10.1177/1759720X14546350
Boyar RM (novembro de 2003). «Control of the onset of puberty». Annual Review of Medicine. 29: 509–20. PMID 206190. doi:10.1146/annurev.me.29.020178.002453
Mahfouda S, Moore JK, Siafarikas A, Zepf FD, Lin A (outubro de 2017). «Puberty suppression in transgender children and adolescents». The Lancet Diabetes & Endocrinology. 5 (10): 816–826. PMID 28546095. doi:10.1016/s2213-8587(17)30099-2
Rafferty J (outubro de 2018). «Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents». Pediatrics. 142 (4): e20182162. PMID 30224363. doi:10.1542/peds.2018-2162
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. (novembro de 2017). «Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline». The Journal of Clinical Endocrinology and Metabolism. 102 (11): 3869–3903. PMID 28945902. doi:10.1210/jc.2017-01658
Bangalore Krishna, Kanthi; Fuqua, John S.; Rogol, Alan D.; Klein, Karen O.; Popovic, Jadranka; Houk, Christopher P.; Charmandari, Evangelia; Lee, Peter A.; Freire, A. V. (2019). «Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium». Hormone Research in Paediatrics. 91 (6): 357–372. ISSN 1663-2826. PMID 31319416. doi:10.1159/000501336
Giovanardi G (setembro de 2017). «Buying time or arresting development? The dilemma of administering hormone blockers in trans children and adolescents». Porto Biomedical Journal. 2 (5): 153–156. PMC 6806792. PMID 32258611. doi:10.1016/j.pbj.2017.06.001
Tuvemo T (maio de 2006). «Treatment of central precocious puberty». Expert Opin Investig Drugs. 15 (5): 495–505. PMID 16634688. doi:10.1517/13543784.15.5.495
Eugster EA (maio de 2019). «Treatment of Central Precocious Puberty». J Endocr Soc. 3 (5): 965–972. PMC 6486823. PMID 31041427. doi:10.1210/js.2019-00036
Roth C (setembro de 2002). «Therapeutic potential of GnRH antagonists in the treatment of precocious puberty». Expert Opin Investig Drugs. 11 (9): 1253–9. PMID 12225246. doi:10.1517/13543784.11.9.1253
Neyman A, Fuqua JS, Eugster EA (abril de 2019). «Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents». J Adolesc Health. 64 (4): 544–546. PMC 6431559. PMID 30612811. doi:10.1016/j.jadohealth.2018.10.296
Schoelwer M, Eugster EA (2016). «Treatment of Peripheral Precocious Puberty». Endocr Dev. Endocrine Development. 29: 230–9. ISBN 978-3-318-02788-4. PMC 5345994. PMID 26680582. doi:10.1159/000438895

pubmed.ncbi.nlm.nih.gov

Rew, Lynn; Young, Cara C.; Monge, Maria; Bogucka, Roxanne (fevereiro de 2021). «Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature». Child and Adolescent Mental Health. 26 (1): 3–14. ISSN 1475-357X. doi:10.1111/camh.12437
Rew, Lynn; Young, Cara; Monge, Maria; Bogucka, Roxanne (2021). «Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature». Child and Adolescent Mental Health. 26 (1): 3–14. doi:10.1111/camh.12437. Consultado em 5 de junho de 2022. Cópia arquivada em 20 de maio de 2022

nytimes.com

Wilson, Lena (11 de maio de 2021). «What Are Puberty Blockers?». The New York Times (em inglês). ISSN 0362-4331. Consultado em 31 de março de 2022

web.archive.org

Rew, Lynn; Young, Cara; Monge, Maria; Bogucka, Roxanne (2021). «Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature». Child and Adolescent Mental Health. 26 (1): 3–14. doi:10.1111/camh.12437. Consultado em 5 de junho de 2022. Cópia arquivada em 20 de maio de 2022

worldcat.org

Rew, Lynn; Young, Cara C.; Monge, Maria; Bogucka, Roxanne (fevereiro de 2021). «Review: Puberty blockers for transgender and gender diverse youth-a critical review of the literature». Child and Adolescent Mental Health. 26 (1): 3–14. ISSN 1475-357X. doi:10.1111/camh.12437
Wilson, Lena (11 de maio de 2021). «What Are Puberty Blockers?». The New York Times (em inglês). ISSN 0362-4331. Consultado em 31 de março de 2022
Bangalore Krishna, Kanthi; Fuqua, John S.; Rogol, Alan D.; Klein, Karen O.; Popovic, Jadranka; Houk, Christopher P.; Charmandari, Evangelia; Lee, Peter A.; Freire, A. V. (2019). «Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium». Hormone Research in Paediatrics. 91 (6): 357–372. ISSN 1663-2826. PMID 31319416. doi:10.1159/000501336